Allergan (AGN) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Allergan Reports Strong Second Quarter 2016 Continuing Operations Performance with Net Revenues of $3.7 Billion
August 8, 2016 7:00 AM EDTDUBLIN, Aug. 8, 2016 /PRNewswire/ --Â Allergan plc (NYSE: AGN) today reported its second quarter 2016 continuing operations performance.Â
Second Quarter 2016 Continuing Operations
($ in millions, except per share amounts)
Q2 '16
Q2 '15
Q1 '16
Q2 '16v Q2'15
Q2 '16v Q1'16
Total net revenues
$ Â Â 3,684.8
$ Â Â ... More
